MYCOPHENOLATE MOFETIL

MYCOPHENOLATE MOFETIL was reported 138560 times

MYCOPHENOLATE MOFETIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SMOOTH MUSCLE CELL NEOPLASM 296 0.7081
1 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1503 0.6409
2 TRICHODYSPLASIA SPINULOSA 242 0.6352
3 RENAL GRAFT INFECTION 145 0.6250
4 TRANSPLANT DYSFUNCTION 1068 0.5980
5 GRIP STRENGTH 135 0.5895
6 MALACOPLAKIA 263 0.5742
7 POLYOMAVIRUS VIRAEMIA 594 0.5593
8 CHRONIC ALLOGRAFT NEPHROPATHY 435 0.5556
9 DELAYED GRAFT FUNCTION 394 0.5541
10 C-REACTIVE PROTEIN 505 0.5448
11 HEART TRANSPLANT REJECTION 560 0.5395
12 PHAEOHYPHOMYCOSIS 257 0.5365
13 MYCOBACTERIUM HAEMOPHILUM INFECTION 149 0.5210
14 TRANSPLANT REJECTION 4167 0.5196
15 SWOLLEN JOINT COUNT 127 0.5080
16 DEEP VEIN THROMBOSIS POSTOPERATIVE 976 0.4873
17 PARVOVIRUS B19 INFECTION 433 0.4838
18 COMPLICATIONS OF TRANSPLANTED HEART 100 0.4651
19 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2342 0.4597
20 COMPLICATIONS OF TRANSPLANTED KIDNEY 1041 0.4586
21 HUMAN POLYOMAVIRUS INFECTION 243 0.4576
22 ALTERNARIA INFECTION 170 0.4570
23 BK VIRUS INFECTION 1497 0.4434
24 LUPUS VULGARIS 553 0.4389
25 RENAL TRANSPLANT FAILURE 431 0.4362
26 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 390 0.4212
27 GRAFT LOSS 295 0.4069
28 COMPLICATIONS OF TRANSPLANTED LUNG 124 0.4039
29 GRAFT DYSFUNCTION 114 0.4000
30 KIDNEY TRANSPLANT REJECTION 1912 0.3981
31 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 551 0.3900
32 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1073 0.3878
33 ACUTE GRAFT VERSUS HOST DISEASE IN LIVER 277 0.3853
34 PULMONARY MUCORMYCOSIS 203 0.3845
35 LUNG TRANSPLANT REJECTION 252 0.3818
36 MICROTIA 120 0.3810
37 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 113 0.3792
38 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 138 0.3791
39 HUMAN HERPESVIRUS 8 INFECTION 228 0.3744
40 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 790 0.3709
41 CYSTITIS VIRAL 142 0.3708
42 SWOLLEN JOINT COUNT INCREASED 1183 0.3706
43 CYTOMEGALOVIRUS VIRAEMIA 1577 0.3541
44 CRYPTOSPORIDIOSIS INFECTION 185 0.3524
45 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 232 0.3473
46 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 125 0.3444
47 VIRAL HAEMORRHAGIC CYSTITIS 240 0.3371
48 GRAFT VERSUS HOST DISEASE IN SKIN 738 0.3347
49 CYTOMEGALOVIRUS INFECTION REACTIVATION 1480 0.3347
50 EPSTEIN-BARR VIRAEMIA 368 0.3318
51 CYTOMEGALOVIRUS OESOPHAGITIS 120 0.3261
52 CHRONIC GRAFT VERSUS HOST DISEASE 1174 0.3248
53 ADENOVIRUS INFECTION 943 0.3248
54 LYMPHOCELE 215 0.3238
55 RETINITIS 559 0.3233
56 ACUTE GRAFT VERSUS HOST DISEASE 1468 0.3204
57 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 660 0.3182
58 GRAFT VERSUS HOST DISEASE IN LUNG 152 0.3180
59 LIVER TRANSPLANT REJECTION 568 0.3159
60 PULMONARY NOCARDIOSIS 259 0.3143
61 TRANSPLANT FAILURE 770 0.3138
62 CEREBRAL TOXOPLASMOSIS 291 0.3116
63 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 1026 0.3103
64 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 361 0.3008
65 CYTOMEGALOVIRUS INFECTION 5001 0.3006
66 RHEUMATIC FEVER 1328 0.2976
67 MICROSPORIDIA INFECTION 103 0.2934
68 RENAL TUBULAR ATROPHY 256 0.2902
69 BLASTOMYCOSIS 140 0.2881
70 DISSEMINATED CRYPTOCOCCOSIS 217 0.2867
71 GRAFT VERSUS HOST DISEASE IN LIVER 204 0.2849
72 CYTOMEGALOVIRUS ENTERITIS 100 0.2809
73 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOMA 166 0.2809
74 DISSEMINATED MUCORMYCOSIS 109 0.2766
75 LUPUS NEPHRITIS 514 0.2746
76 FACET JOINT SYNDROME 883 0.2709
77 CAT SCRATCH DISEASE 107 0.2662
78 EPSTEIN-BARR VIRUS INFECTION 1661 0.2656
79 CYTOMEGALOVIRUS COLITIS 603 0.2619
80 SCEDOSPORIUM INFECTION 183 0.2592
81 DISLOCATION OF VERTEBRA 590 0.2584
82 VARICELLA ZOSTER VIRUS INFECTION 531 0.2559
83 INFECTION REACTIVATION 293 0.2559
84 X-RAY ABNORMAL 456 0.2547
85 WEST NILE VIRAL INFECTION 190 0.2533
86 UREAPLASMA INFECTION 102 0.2500
87 HUMAN HERPESVIRUS 6 INFECTION 466 0.2463
88 TOXOPLASMOSIS 266 0.2463
89 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 426 0.2408
90 PNEUMONIA CYTOMEGALOVIRAL 467 0.2402
91 OVERLAP SYNDROME 167 0.2386
92 JC VIRUS INFECTION 378 0.2362
93 MUCORMYCOSIS 608 0.2338
94 NOCARDIOSIS 597 0.2332
95 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 360 0.2246
96 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 293 0.2225
97 RENAL TUBULAR INJURY 270 0.2222
98 CRYPTOCOCCOSIS 361 0.2213
99 VIRAEMIA 305 0.2201
100 HISTOPLASMOSIS DISSEMINATED 348 0.2191
101 STRONGYLOIDIASIS 347 0.2146
102 RHEUMATOID FACTOR POSITIVE 1236 0.2138
103 GRAFT COMPLICATION 122 0.2078
104 MENINGITIS CRYPTOCOCCAL 351 0.2006
105 GRAFT VERSUS HOST DISEASE 1443 0.2005
106 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 104 0.1985
107 DUODENAL ULCER PERFORATION 1474 0.1980
108 INFECTION IN AN IMMUNOCOMPROMISED HOST 141 0.1964
109 HEPATITIS E 310 0.1962
110 CYTOMEGALOVIRUS TEST POSITIVE 345 0.1934
111 CENTRAL NERVOUS SYSTEM LYMPHOMA 266 0.1929
112 STENOTROPHOMONAS INFECTION 260 0.1916
113 KIDNEY FIBROSIS 332 0.1912
114 C-REACTIVE PROTEIN ABNORMAL 1190 0.1853
115 PNEUMOCYSTIS JIROVECII INFECTION 219 0.1833
116 ENCEPHALITIS VIRAL 223 0.1831
117 THROMBOTIC MICROANGIOPATHY 1749 0.1793
118 EPSTEIN-BARR VIRUS TEST POSITIVE 112 0.1775
119 SYSTEMIC MYCOSIS 205 0.1755
120 CYSTITIS HAEMORRHAGIC 700 0.1735
121 OBLITERATIVE BRONCHIOLITIS 225 0.1714
122 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 138 0.1697
123 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1103 0.1697
124 ALVEOLAR PROTEINOSIS 100 0.1689
125 URETERIC STENOSIS 135 0.1685
126 ASPERGILLUS INFECTION 1101 0.1676
127 KLEBSIELLA INFECTION 848 0.1675
128 PORPHYRIA ACUTE 234 0.1631
129 MYCOBACTERIUM CHELONAE INFECTION 119 0.1610
130 MYCOPLASMA INFECTION 125 0.1601
131 BRAIN ABSCESS 403 0.1591
132 ACINETOBACTER INFECTION 172 0.1571
133 BONE EROSION 555 0.1568
134 SERONEGATIVE ARTHRITIS 178 0.1553
135 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1105 0.1541
136 FUSARIUM INFECTION 105 0.1500
137 VISCERAL LEISHMANIASIS 108 0.1496
138 ENTEROCOCCAL INFECTION 723 0.1495
139 MUSCLE INJURY 1209 0.1458
140 MYCOBACTERIUM ABSCESSUS INFECTION 104 0.1455
141 CYTOMEGALOVIRUS CHORIORETINITIS 283 0.1450
142 HELICOBACTER INFECTION 1491 0.1449
143 KLEBSIELLA BACTERAEMIA 137 0.1442
144 MYCOBACTERIAL INFECTION 248 0.1439
145 ENTEROCOCCAL BACTERAEMIA 152 0.1434
146 APLASIA PURE RED CELL 482 0.1400
147 HISTOPLASMOSIS 246 0.1388
148 PNEUMONIA CRYPTOCOCCAL 129 0.1365
149 VACCINATION FAILURE 227 0.1364
150 FOLLICULITIS 1428 0.1360
151 BRONCHOPULMONARY ASPERGILLOSIS 1044 0.1345
152 HERPES ZOSTER DISSEMINATED 108 0.1345
153 PERIPHERAL VENOUS DISEASE 548 0.1341
154 PNEUMOCYSTIS JIROVECII PNEUMONIA 1271 0.1265
155 GASTROENTERITIS NOROVIRUS 168 0.1264
156 SUPERINFECTION BACTERIAL 100 0.1261
157 PEMPHIGUS 1578 0.1261
158 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 99 0.1256
159 ENTEROBACTER INFECTION 210 0.1249
160 URINARY TRACT INFECTION ENTEROCOCCAL 114 0.1221
161 LIP DRY 1081 0.1189
162 STEROID DEPENDENCE 103 0.1173
163 HAND DEFORMITY 1520 0.1158
164 ENTEROVIRUS INFECTION 99 0.1146
165 PSEUDOMONAS INFECTION 983 0.1145
166 BLOOD PRESSURE DIASTOLIC ABNORMAL 291 0.1143
167 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1089 0.1140
168 IGA NEPHROPATHY 189 0.1139
169 AUTOIMMUNE DISORDER 1095 0.1122
170 ANOGENITAL WARTS 100 0.1121
171 PNEUMONIA KLEBSIELLA 206 0.1120
172 STEROID DIABETES 166 0.1106
173 HYPOGAMMAGLOBULINAEMIA 715 0.1087
174 GLOMERULONEPHRITIS 266 0.1086
175 HAEMOLYTIC URAEMIC SYNDROME 249 0.1073
176 BLOOD IRON ABNORMAL 104 0.1064
177 AMAUROSIS FUGAX 114 0.1058
178 BREAST CANCER STAGE III 681 0.1050
179 PNEUMATOSIS INTESTINALIS 298 0.1044
180 NOROVIRUS INFECTION 149 0.1032
181 BACTERIAL SEPSIS 336 0.1031
182 VENOOCCLUSIVE LIVER DISEASE 507 0.1026
183 SYSTEMIC CANDIDA 257 0.1023
184 KLEBSIELLA SEPSIS 115 0.1020
185 ATYPICAL MYCOBACTERIAL INFECTION 144 0.1018
186 PAPILLOMA VIRAL INFECTION 168 0.1018
187 GINGIVAL HYPERTROPHY 154 0.1014
188 WOUND INFECTION 1112 0.1014
189 SCIATICA 1610 0.1009
190 ASPERGILLOSIS 131 0.1002
191 JOINT RANGE OF MOTION DECREASED 1336 0.0995
192 ESCHERICHIA INFECTION 816 0.0991
193 ACUTE MYELOID LEUKAEMIA RECURRENT 210 0.0977
194 PYELONEPHRITIS ACUTE 191 0.0973
195 CUSHINGOID 307 0.0955
196 VENOOCCLUSIVE DISEASE 237 0.0946
197 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 709 0.0944
198 DIFFUSE LARGE B-CELL LYMPHOMA 719 0.0932
199 NEPHROPATHY TOXIC 1044 0.0929
200 LYMPHOPROLIFERATIVE DISORDER 273 0.0929
201 ACTINIC KERATOSIS 240 0.0924
202 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 244 0.0917
203 CENTRAL NERVOUS SYSTEM INFECTION 105 0.0916
204 SYNOVITIS 1645 0.0911
205 RENAL ARTERY STENOSIS 124 0.0899
206 DRUG TOLERANCE DECREASED 252 0.0896
207 BLOOD PRESSURE SYSTOLIC ABNORMAL 220 0.0889
208 PNEUMONIA PSEUDOMONAL 132 0.0860
209 FUNGAEMIA 135 0.0857
210 HERPES SIMPLEX 555 0.0853
211 PARAINFLUENZAE VIRUS INFECTION 129 0.0847
212 PERICARDITIS 1414 0.0841
213 PNEUMONIA FUNGAL 330 0.0836
214 TRANSITIONAL CELL CARCINOMA 108 0.0832
215 DISSEMINATED TUBERCULOSIS 212 0.0826
216 BILE DUCT STENOSIS 98 0.0817
217 NEPHROTIC SYNDROME 554 0.0807
218 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2194 0.0774
219 SQUAMOUS CELL CARCINOMA OF SKIN 458 0.0758
220 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 624 0.0756
221 ENCEPHALITIS AUTOIMMUNE 99 0.0753
222 SOFT TISSUE INFECTION 137 0.0748
223 NORMOCYTIC ANAEMIA 109 0.0741
224 MATERNAL EXPOSURE TIMING UNSPECIFIED 278 0.0739
225 GRIP STRENGTH DECREASED 651 0.0739
226 HYPERCHOLESTEROLAEMIA 712 0.0737
227 URINARY TRACT INFECTION BACTERIAL 186 0.0735
228 LIVE BIRTH 614 0.0733
229 ESCHERICHIA BACTERAEMIA 172 0.0731
230 RENAL TUBULAR NECROSIS 708 0.0721
231 OPPORTUNISTIC INFECTION 130 0.0702
232 SCLERODERMA 255 0.0701
233 FUNGAL SKIN INFECTION 283 0.0700
234 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 138 0.0698
235 SYSTEMIC LUPUS ERYTHEMATOSUS 2449 0.0689
236 BACTERAEMIA 812 0.0684
237 INFECTIOUS PLEURAL EFFUSION 103 0.0676
238 ESCHERICHIA SEPSIS 196 0.0676
239 PNEUMOMEDIASTINUM 122 0.0674
240 GLOSSODYNIA 1506 0.0672
241 DERMATOMYOSITIS 167 0.0659
242 STAPHYLOCOCCAL BACTERAEMIA 286 0.0657
243 RED BLOOD CELL SEDIMENTATION RATE INCREASED 727 0.0656
244 BURSITIS 795 0.0655
245 IRRITABLE BOWEL SYNDROME 1393 0.0649
246 ACUTE RESPIRATORY DISTRESS SYNDROME 1137 0.0642
247 RENAL TUBULAR ACIDOSIS 140 0.0641
248 VARICELLA 153 0.0640
249 FIBROMYALGIA 1541 0.0633
250 RHINOVIRUS INFECTION 244 0.0626
251 PYELONEPHRITIS 538 0.0620
252 COVID-19 PNEUMONIA 733 0.0620
253 ESCHERICHIA URINARY TRACT INFECTION 263 0.0618
254 LOWER LIMB FRACTURE 1179 0.0613
255 PROTEINURIA 1164 0.0612
256 PULMONARY FIBROSIS 1171 0.0610
257 RENAL TRANSPLANT 217 0.0600
258 ORGANISING PNEUMONIA 294 0.0593
259 MYCOBACTERIUM AVIUM COMPLEX INFECTION 156 0.0581
260 PNEUMONIA BACTERIAL 520 0.0566
261 HISTIOCYTOSIS HAEMATOPHAGIC 167 0.0562
262 SEPTIC SHOCK 2447 0.0562
263 WOUND 1550 0.0554
264 PNEUMOPERITONEUM 102 0.0552
265 LIVER INJURY 1352 0.0550
266 RENAL TUBULAR DISORDER 153 0.0543
267 LUPUS-LIKE SYNDROME 489 0.0539
268 AUTOIMMUNE HAEMOLYTIC ANAEMIA 182 0.0530
269 PNEUMONIA VIRAL 168 0.0526
270 LUNG ABSCESS 110 0.0524
271 LIVER ABSCESS 170 0.0524
272 PRESCRIBED OVERDOSE 1013 0.0523
273 EMPYEMA 104 0.0523
274 EXOSTOSIS 473 0.0517
275 ENCEPHALITIS 355 0.0513
276 HAEMATOLOGICAL INFECTION 125 0.0511
277 HYDRONEPHROSIS 377 0.0503
278 IMPAIRED HEALING 1641 0.0499
279 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 242 0.0485
280 LEUKOPENIA 2418 0.0483
281 WOUND DEHISCENCE 163 0.0482
282 TYPE 2 DIABETES MELLITUS 1621 0.0481
283 LYMPHOPENIA 677 0.0478
284 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 110 0.0477
285 NEPHROGENIC SYSTEMIC FIBROSIS 144 0.0476
286 B-CELL LYMPHOMA 161 0.0474
287 HEPATIC FIBROSIS 162 0.0472
288 FIBROSIS 145 0.0471
289 PATHOGEN RESISTANCE 429 0.0470
290 HEPATITIS B REACTIVATION 149 0.0469
291 PULMONARY ALVEOLAR HAEMORRHAGE 263 0.0468
292 PULMONARY TUBERCULOSIS 200 0.0468
293 OBESITY 745 0.0467
294 WALKING AID USER 308 0.0467
295 SERUM SICKNESS 129 0.0462
296 BRONCHIECTASIS 311 0.0461
297 CLOSTRIDIUM DIFFICILE COLITIS 488 0.0460
298 BLOOD IMMUNOGLOBULIN G DECREASED 114 0.0460
299 APLASTIC ANAEMIA 239 0.0457
300 ENDOCARDITIS 231 0.0450
301 THERAPY NON-RESPONDER 2024 0.0450
302 ARTHRITIS BACTERIAL 183 0.0445
303 PSORIATIC ARTHROPATHY 1807 0.0445
304 ABDOMINAL INFECTION 111 0.0434
305 SQUAMOUS CELL CARCINOMA 404 0.0429
306 MYASTHENIA GRAVIS 346 0.0428
307 DRUG LEVEL INCREASED 703 0.0424
308 PRESCRIBED UNDERDOSE 845 0.0423
309 GRANULOMA 146 0.0421
310 LUNG CONSOLIDATION 117 0.0418
311 STAPHYLOCOCCAL SEPSIS 206 0.0417
312 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 158 0.0413
313 CANDIDA INFECTION 691 0.0409
314 OESOPHAGEAL CANDIDIASIS 163 0.0409
315 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2244 0.0409
316 GROWTH RETARDATION 120 0.0407
317 AGRANULOCYTOSIS 755 0.0406
318 OVARIAN CYST 406 0.0406
319 IMMUNOSUPPRESSION 354 0.0401
320 JOINT DISLOCATION 422 0.0399
321 LARGE INTESTINAL ULCER 108 0.0397
322 HEPATOSPLENOMEGALY 102 0.0397
323 HEPATIC NECROSIS 149 0.0395
324 ENTERITIS 252 0.0393
325 SKIN PAPILLOMA 157 0.0391
326 THERAPY PARTIAL RESPONDER 607 0.0389
327 IMMUNE THROMBOCYTOPENIA 178 0.0388
328 HERPES VIRUS INFECTION 222 0.0385
329 UROSEPSIS 354 0.0383
330 LEUKOENCEPHALOPATHY 142 0.0381
331 MYOPATHY 329 0.0381
332 BACTERIAL INFECTION 709 0.0380
333 CHOLANGITIS 235 0.0379
334 OLIGURIA 235 0.0378
335 HYPERVOLAEMIA 187 0.0378
336 SUSPECTED OFF LABEL USE 169 0.0374
337 HEPATITIS C 451 0.0373
338 NECROTISING FASCIITIS 131 0.0371
339 HAEMODYNAMIC INSTABILITY 282 0.0370
340 CYTOPENIA 453 0.0370
341 SHOCK HAEMORRHAGIC 300 0.0368
342 TREATMENT FAILURE 3040 0.0367
343 OESOPHAGEAL STENOSIS 103 0.0362
344 SKIN HYPERTROPHY 101 0.0359
345 BRAIN HERNIATION 107 0.0358
346 BREAST CANCER STAGE II 298 0.0358
347 POLYARTHRITIS 187 0.0354
348 NECROSIS 197 0.0354
349 DRUG RESISTANCE 906 0.0352
350 GUILLAIN-BARRE SYNDROME 170 0.0351
351 BLOOD CREATININE INCREASED 2289 0.0350
352 FOOT DEFORMITY 386 0.0348
353 ULCER HAEMORRHAGE 235 0.0347
354 RENAL CELL CARCINOMA 169 0.0345
355 ENTEROCOLITIS 199 0.0344
356 RESPIRATORY FAILURE 2510 0.0344
357 PANCYTOPENIA 1919 0.0343
358 INTENTIONAL PRODUCT USE ISSUE 2979 0.0340
359 HEPATIC CIRRHOSIS 634 0.0337
360 NORMOCHROMIC NORMOCYTIC ANAEMIA 101 0.0336
361 NEPHRITIS 112 0.0335
362 HYPERTRANSAMINASAEMIA 233 0.0335
363 STAPHYLOCOCCAL INFECTION 1103 0.0334
364 DYSLIPIDAEMIA 169 0.0332
365 OEDEMA 1798 0.0331
366 MYOSITIS 297 0.0331
367 MUCOSAL INFLAMMATION 860 0.0328
368 HIP ARTHROPLASTY 503 0.0328
369 ANURIA 281 0.0326
370 RENAL IMPAIRMENT 2741 0.0326
371 GAIT INABILITY 1088 0.0325
372 LUNG DISORDER 1589 0.0324
373 ROAD TRAFFIC ACCIDENT 1354 0.0323
374 HEPATITIS B 195 0.0323
375 END STAGE RENAL DISEASE 590 0.0323
376 ENDOPHTHALMITIS 193 0.0321
377 OESOPHAGEAL ULCER 123 0.0320
378 LIVER TRANSPLANT 115 0.0316
379 LUNG INFILTRATION 279 0.0316
380 ACUTE RESPIRATORY FAILURE 607 0.0315
381 THROMBOTIC THROMBOCYTOPENIC PURPURA 111 0.0315
382 SEPSIS 3491 0.0313
383 CONTRAINDICATED PRODUCT ADMINISTERED 947 0.0312
384 NIGHT SWEATS 1005 0.0312
385 LIVER DISORDER 1379 0.0311
386 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 532 0.0310
387 DRUG LEVEL ABOVE THERAPEUTIC 142 0.0310
388 NEUROTOXICITY 542 0.0309
389 HYPERURICAEMIA 127 0.0309
390 HAEMOLYTIC ANAEMIA 276 0.0308
391 HAEMODIALYSIS 256 0.0305
392 AUTOIMMUNE HEPATITIS 212 0.0305
393 LOWER RESPIRATORY TRACT INFECTION 1380 0.0303
394 MULTI-ORGAN FAILURE 521 0.0301
395 DISSEMINATED INTRAVASCULAR COAGULATION 421 0.0299
396 PRODUCT USE IN UNAPPROVED INDICATION 7406 0.0299
397 INFUSION RELATED REACTION 1979 0.0298
398 PULMONARY FUNCTION TEST DECREASED 130 0.0297
399 TUBULOINTERSTITIAL NEPHRITIS 556 0.0296
400 RALES 172 0.0296
401 GLUCOSE TOLERANCE IMPAIRED 175 0.0296
402 DRUG INTOLERANCE 2855 0.0295
403 AZOTAEMIA 118 0.0295
404 LEFT VENTRICULAR HYPERTROPHY 125 0.0292
405 ODYNOPHAGIA 173 0.0290
406 URINARY TRACT DISORDER 130 0.0288
407 REBOUND EFFECT 325 0.0287
408 DISEASE RECURRENCE 1366 0.0287
409 ASCITES 844 0.0287
410 RESPIRATORY SYNCYTIAL VIRUS INFECTION 248 0.0285
411 CARDIAC TAMPONADE 135 0.0284
412 OSTEOARTHRITIS 1204 0.0284
413 HYPERCALCAEMIA 350 0.0283
414 BLOOD PRESSURE DIASTOLIC INCREASED 130 0.0281
415 BLOOD CREATININE ABNORMAL 97 0.0280
416 C-REACTIVE PROTEIN INCREASED 1019 0.0280
417 INFLAMMATION 1437 0.0278
418 CACHEXIA 143 0.0278
419 SPONDYLITIS 101 0.0277
420 VASCULITIS 323 0.0277
421 INFECTION 3995 0.0276
422 PYODERMA GANGRENOSUM 99 0.0275
423 HEPATITIS CHOLESTATIC 165 0.0274
424 BASAL CELL CARCINOMA 427 0.0273
425 BLOOD CHOLESTEROL INCREASED 1272 0.0273
426 MENINGITIS 182 0.0272
427 STOMATITIS 1644 0.0271
428 HYPERAMMONAEMIA 135 0.0270
429 SUBCUTANEOUS ABSCESS 129 0.0269
430 HEPATOCELLULAR CARCINOMA 204 0.0268
431 GENERALISED OEDEMA 332 0.0268
432 HEPATIC ENZYME INCREASED 1813 0.0266
433 FUNGAL INFECTION 884 0.0265
434 MENINGITIS ASEPTIC 119 0.0265
435 POSTOPERATIVE WOUND INFECTION 179 0.0265
436 BONE MARROW FAILURE 538 0.0264
437 CANDIDIASIS 106 0.0264
438 PULMONARY HAEMORRHAGE 206 0.0263
439 HYPERBILIRUBINAEMIA 272 0.0262
440 SPLENOMEGALY 306 0.0261
441 SKIN NECROSIS 135 0.0260
442 ENCEPHALOPATHY 638 0.0260
443 ACUTE KIDNEY INJURY 3956 0.0258
444 UVEITIS 349 0.0257
445 GASTROINTESTINAL TOXICITY 123 0.0256
446 INTERSTITIAL LUNG DISEASE 1238 0.0255
447 URINE OUTPUT DECREASED 222 0.0254
448 BLEPHAROSPASM 159 0.0252
449 WHEEZING 1492 0.0251
450 HYPOALBUMINAEMIA 195 0.0251
451 OSTEOPOROSIS 1029 0.0250
452 GASTROINTESTINAL DISORDER 2229 0.0249
453 PROTEIN URINE PRESENT 124 0.0248
454 DELIRIUM 862 0.0248
455 LARGE INTESTINE PERFORATION 171 0.0246
456 BLISTER 1382 0.0246
457 INTRACRANIAL PRESSURE INCREASED 137 0.0246
458 PNEUMONIA ASPIRATION 611 0.0244
459 ARTHROPATHY 1358 0.0244
460 NEPHROPATHY 227 0.0243
461 FAILURE TO THRIVE 126 0.0242
462 LUNG INFECTION 376 0.0242
463 DRUG TOLERANCE 122 0.0241
464 SKIN INFECTION 269 0.0240
465 HYPERTRIGLYCERIDAEMIA 140 0.0239
466 JOINT STIFFNESS 623 0.0237
467 MUSCULOSKELETAL PAIN 1243 0.0237
468 HYPERKALAEMIA 832 0.0237
469 STREPTOCOCCAL INFECTION 132 0.0237
470 BLOOD CREATINE INCREASED 105 0.0237
471 PREGNANCY 474 0.0236
472 PERICARDIAL EFFUSION 547 0.0236
473 COLITIS 895 0.0236
474 GASTROENTERITIS 343 0.0235
475 TOXIC ENCEPHALOPATHY 119 0.0235
476 HAEMOLYSIS 180 0.0233
477 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 239 0.0233
478 OFF LABEL USE 20291 0.0231
479 CHOLESTASIS 444 0.0231
480 HYPERLIPIDAEMIA 275 0.0230
481 HYDROCEPHALUS 125 0.0229
482 GLOMERULAR FILTRATION RATE DECREASED 281 0.0228
483 MOBILITY DECREASED 1642 0.0228
484 HERPES ZOSTER 1311 0.0228
485 ACUTE HEPATIC FAILURE 307 0.0224
486 CARDIAC FAILURE ACUTE 148 0.0222
487 DRUG LEVEL DECREASED 226 0.0222
488 MOUTH ULCERATION 467 0.0221
489 KNEE ARTHROPLASTY 465 0.0221
490 ANGIOPATHY 123 0.0219
491 HAEMATURIA 751 0.0219
492 RASH VESICULAR 106 0.0219
493 ILL-DEFINED DISORDER 1317 0.0217
494 ADRENAL INSUFFICIENCY 263 0.0217
495 BLOOD ALBUMIN DECREASED 171 0.0215
496 IMMUNODEFICIENCY 321 0.0215
497 ACIDOSIS 164 0.0214
498 DEVICE RELATED INFECTION 330 0.0214
499 METASTASES TO LYMPH NODES 144 0.0213
500 DRUG INTERACTION 3371 0.0212
501 PERITONITIS 438 0.0211
502 PULMONARY MASS 315 0.0211
503 APHTHOUS ULCER 164 0.0211
504 CHRONIC MYELOID LEUKAEMIA 97 0.0210
505 BLOOD PRESSURE SYSTOLIC INCREASED 409 0.0210
506 TYPE 1 DIABETES MELLITUS 126 0.0209
507 HAEMORRHAGIC STROKE 163 0.0209
508 SKIN MASS 139 0.0208
509 INJURY 1463 0.0208
510 DRUG-INDUCED LIVER INJURY 652 0.0208
511 OESOPHAGITIS 226 0.0207
512 SINUSITIS 2120 0.0207
513 DISCOMFORT 1259 0.0206
514 THERAPEUTIC PRODUCT EFFECT DECREASED 924 0.0206
515 BLOOD PRESSURE DIASTOLIC DECREASED 152 0.0206
516 PLEURISY 122 0.0205
517 CLOSTRIDIUM DIFFICILE INFECTION 443 0.0203
518 SKIN LESION 555 0.0202
519 HEPATOTOXICITY 450 0.0202
520 COVID-19 3542 0.0202
521 BRAIN OEDEMA 255 0.0202
522 ATELECTASIS 195 0.0202
523 HYPOVOLAEMIA 118 0.0201
524 MYOCARDITIS 231 0.0201
525 MALABSORPTION 105 0.0201
526 HAEMATOTOXICITY 191 0.0201
527 RESPIRATORY DISTRESS 554 0.0201
528 MATERNAL EXPOSURE DURING PREGNANCY 1769 0.0198
529 EAR INFECTION 528 0.0198
530 NEUTROPENIA 2685 0.0197
531 RHEUMATOID ARTHRITIS 2223 0.0196
532 MULTIPLE ALLERGIES 153 0.0195
533 HYPOXIA 679 0.0193
534 FEBRILE NEUTROPENIA 1270 0.0191
535 NORMAL NEWBORN 104 0.0191
536 RESPIRATORY TRACT INFECTION 498 0.0191
537 ACUTE MYELOID LEUKAEMIA 296 0.0190
538 BLOOD UREA INCREASED 318 0.0190
539 GASTROINTESTINAL INFECTION 170 0.0189
540 RESPIRATORY DISORDER 566 0.0189
541 UPPER RESPIRATORY TRACT INFECTION 872 0.0189
542 CARDIOGENIC SHOCK 270 0.0188
543 THROMBOCYTOPENIA 2099 0.0188
544 NAIL DISORDER 164 0.0187
545 ORAL DISORDER 137 0.0187
546 COAGULOPATHY 311 0.0186
547 GENERAL PHYSICAL HEALTH DETERIORATION 2158 0.0186
548 MALNUTRITION 208 0.0186
549 LIVER FUNCTION TEST INCREASED 398 0.0185
550 ABSCESS 295 0.0185
551 PNEUMOTHORAX 293 0.0185
552 SWELLING 1715 0.0183
553 METABOLIC ACIDOSIS 583 0.0182
554 TRANSAMINASES INCREASED 405 0.0182
555 EAR PAIN 354 0.0182
556 NEUROLOGICAL SYMPTOM 104 0.0182
557 HEPATIC FAILURE 547 0.0181
558 BLOOD BILIRUBIN INCREASED 490 0.0181
559 DIARRHOEA HAEMORRHAGIC 168 0.0180
560 STATUS EPILEPTICUS 202 0.0179
561 HEPATITIS 457 0.0178
562 INTESTINAL ISCHAEMIA 98 0.0178
563 OSTEOMYELITIS 322 0.0178
564 JOINT SWELLING 2140 0.0177
565 RENAL FAILURE CHRONIC 136 0.0177
566 PEMPHIGOID 132 0.0175
567 PULMONARY HYPERTENSION 363 0.0174
568 SHOCK 397 0.0172
569 GASTRIC ULCER 327 0.0172
570 ORAL CANDIDIASIS 226 0.0171
571 MUSCULOSKELETAL STIFFNESS 1499 0.0171
572 HYPOMAGNESAEMIA 238 0.0171
573 PNEUMONIA 5505 0.0170
574 HAEMORRHAGE INTRACRANIAL 253 0.0169
575 SKIN ULCER 437 0.0169
576 PYREXIA 5821 0.0168
577 IRON DEFICIENCY ANAEMIA 155 0.0168
578 CORONAVIRUS INFECTION 111 0.0168
579 DUODENAL ULCER 117 0.0166
580 HYPERTENSION 3503 0.0165
581 PLEURAL EFFUSION 1004 0.0165
582 VIRAL INFECTION 549 0.0165
583 BLOOD LACTATE DEHYDROGENASE INCREASED 261 0.0165
584 PAPULE 115 0.0163
585 DRY MOUTH 1323 0.0163
586 DIABETES MELLITUS 1242 0.0163
587 LIVER FUNCTION TEST ABNORMAL 473 0.0162
588 JOINT EFFUSION 112 0.0162
589 COMA 772 0.0162
590 EXPOSURE DURING PREGNANCY 1006 0.0162
591 METASTASES TO LUNG 187 0.0162
592 NEUTROPENIC SEPSIS 114 0.0159
593 DYSPNOEA EXERTIONAL 598 0.0159
594 LEUKOCYTOSIS 287 0.0158
595 PANCREATITIS ACUTE 355 0.0158
596 METASTASIS 112 0.0157
597 HEPATOMEGALY 154 0.0157
598 DIPLOPIA 406 0.0156
599 SLEEP DISORDER 1095 0.0155
600 HEPATIC ENCEPHALOPATHY 144 0.0154
601 RENAL FAILURE 2048 0.0154
602 RIGHT VENTRICULAR FAILURE 107 0.0153
603 CONDITION AGGRAVATED 4626 0.0152
604 MITRAL VALVE INCOMPETENCE 172 0.0152
605 RENAL FAILURE ACUTE 634 0.0149
606 OSTEOPENIA 226 0.0149
607 HEMIPARESIS 252 0.0149
608 ARTERIOSCLEROSIS 139 0.0148
609 DIALYSIS 208 0.0146
610 HYPOPHOSPHATAEMIA 108 0.0146
611 ANAEMIA 2786 0.0146
612 BLOOD PRESSURE FLUCTUATION 350 0.0146
613 PNEUMONITIS 396 0.0145
614 CELLULITIS 731 0.0145
615 URINARY TRACT INFECTION 2456 0.0144
616 CONTUSION 1386 0.0144
617 PURPURA 127 0.0143
618 MYELODYSPLASTIC SYNDROME 207 0.0143
619 PRODUCT PRESCRIBING ISSUE 311 0.0143
620 HAEMATOCRIT DECREASED 283 0.0143
621 EPILEPSY 436 0.0142
622 EYELID PTOSIS 144 0.0142
623 HYPERGLYCAEMIA 516 0.0141
624 ULCER 225 0.0141
625 ORAL HERPES 275 0.0141
626 SUBARACHNOID HAEMORRHAGE 143 0.0140
627 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 124 0.0140
628 ILEUS 174 0.0140
629 MALIGNANT MELANOMA 187 0.0139
630 ALTERED STATE OF CONSCIOUSNESS 302 0.0139
631 OSTEONECROSIS 457 0.0139
632 HEPATIC FUNCTION ABNORMAL 516 0.0138
633 DISEASE PROGRESSION 1627 0.0137
634 LOW BIRTH WEIGHT BABY 109 0.0137
635 INFLAMMATORY BOWEL DISEASE 134 0.0137
636 MYOCLONUS 163 0.0137
637 OEDEMA PERIPHERAL 1665 0.0136
638 AMNESIA 883 0.0136
639 LYMPHADENOPATHY 479 0.0135
640 HYPOAESTHESIA 2023 0.0135
641 DISABILITY 267 0.0135
642 TRICUSPID VALVE INCOMPETENCE 107 0.0135
643 MENTAL STATUS CHANGES 374 0.0135
644 INFUSION SITE PAIN 173 0.0134
645 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 228 0.0134
646 LYMPHOMA 205 0.0133
647 HEPATOCELLULAR INJURY 188 0.0132
648 PULMONARY ARTERIAL HYPERTENSION 191 0.0132
649 CENTRAL NERVOUS SYSTEM LESION 181 0.0132
650 OXYGEN SATURATION DECREASED 740 0.0132
651 TOXICITY TO VARIOUS AGENTS 2211 0.0131
652 PREMATURE DELIVERY 208 0.0130
653 FACIAL PARALYSIS 111 0.0130
654 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 380 0.0130
655 SMALL INTESTINAL OBSTRUCTION 159 0.0129
656 RESPIRATORY RATE INCREASED 114 0.0128
657 OPTIC NEURITIS 116 0.0128
658 BLOOD ALKALINE PHOSPHATASE INCREASED 316 0.0127
659 MUSCULAR WEAKNESS 1446 0.0127
660 GAMMA-GLUTAMYLTRANSFERASE INCREASED 280 0.0126
661 GENERALISED TONIC-CLONIC SEIZURE 208 0.0126
662 MUSCLE ATROPHY 159 0.0125
663 WEIGHT FLUCTUATION 130 0.0124
664 THERAPEUTIC RESPONSE DECREASED 750 0.0124
665 FLUID OVERLOAD 180 0.0124
666 CARDIOMYOPATHY 182 0.0123
667 FREQUENT BOWEL MOVEMENTS 332 0.0123
668 PANCREATITIS 644 0.0122
669 ABDOMINAL DISCOMFORT 2042 0.0122
670 BLINDNESS 496 0.0122
671 PHOTOSENSITIVITY REACTION 200 0.0121
672 SKIN CANCER 258 0.0120
673 DIVERTICULITIS 331 0.0119
674 ALOPECIA 2326 0.0118
675 GOUT 212 0.0118
676 COLITIS ULCERATIVE 522 0.0117
677 CONFUSIONAL STATE 1884 0.0116
678 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 553 0.0115
679 WHITE BLOOD CELL COUNT INCREASED 441 0.0115
680 INTESTINAL PERFORATION 129 0.0115
681 PHOTOPHOBIA 214 0.0114
682 WEIGHT INCREASED 2543 0.0113
683 PULMONARY OEDEMA 504 0.0112
684 TACHYPNOEA 153 0.0112
685 OCULAR DISCOMFORT 126 0.0112
686 ARTHRITIS 879 0.0112
687 CEREBRAL INFARCTION 273 0.0112
688 ALANINE AMINOTRANSFERASE INCREASED 686 0.0112
689 PERIPHERAL SWELLING 1717 0.0111
690 DIARRHOEA 7190 0.0111
691 TUMOUR LYSIS SYNDROME 98 0.0111
692 ELECTROLYTE IMBALANCE 129 0.0111
693 CATARACT 660 0.0111
694 RENAL DISORDER 516 0.0111
695 MYELOSUPPRESSION 398 0.0110
696 NEOPLASM 127 0.0110
697 HAEMATOMA 285 0.0110
698 FLANK PAIN 103 0.0110
699 DYSPEPSIA 1063 0.0108
700 KIDNEY INFECTION 211 0.0107
701 ATAXIA 127 0.0107
702 PRODUCTIVE COUGH 510 0.0107
703 TACHYCARDIA 949 0.0107
704 DECREASED APPETITE 2472 0.0106
705 GLAUCOMA 204 0.0106
706 DRUG TOXICITY 144 0.0106
707 TREATMENT NONCOMPLIANCE 577 0.0105
708 LABORATORY TEST ABNORMAL 309 0.0105
709 ASTHMA 1183 0.0105
710 GASTRITIS 275 0.0104
711 CARDIOMEGALY 128 0.0104
712 HAEMOPTYSIS 289 0.0104
713 NEUTROPHIL COUNT INCREASED 106 0.0103
714 HEPATIC CYTOLYSIS 131 0.0103
715 SEASONAL ALLERGY 145 0.0102
716 DIABETIC KETOACIDOSIS 246 0.0102
717 HAEMOGLOBIN DECREASED 1050 0.0102
718 WEIGHT DECREASED 2850 0.0102
719 ABDOMINAL PAIN 2372 0.0102
720 ABORTION SPONTANEOUS 408 0.0102
721 CIRCULATORY COLLAPSE 173 0.0101
722 CHRONIC KIDNEY DISEASE 771 0.0101
723 CARDIAC FAILURE 813 0.0101
724 NASOPHARYNGITIS 1860 0.0101
725 CYTOKINE RELEASE SYNDROME 202 0.0101
726 CHEST PAIN 1855 0.0100
727 GASTROOESOPHAGEAL REFLUX DISEASE 803 0.0100
728 PRODUCT USE ISSUE 1872 0.0100
729 HYPONATRAEMIA 561 0.0099
730 MASS 139 0.0099
731 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 704 0.0099
732 HYPERSENSITIVITY 1824 0.0098
733 URTICARIA 1618 0.0096
734 ASPIRATION 105 0.0096
735 PETECHIAE 100 0.0096
736 JAUNDICE 256 0.0095
737 BODY TEMPERATURE INCREASED 194 0.0095
738 HYPOCALCAEMIA 179 0.0094
739 CYSTITIS 300 0.0094
740 POST PROCEDURAL COMPLICATION 180 0.0094
741 BLOOD POTASSIUM INCREASED 152 0.0094
742 CEREBRAL HAEMORRHAGE 333 0.0093
743 RECTAL HAEMORRHAGE 399 0.0093
744 INTRAOCULAR PRESSURE INCREASED 118 0.0092
745 HAEMATEMESIS 234 0.0092
746 POLYNEUROPATHY 110 0.0092
747 LYMPHOCYTE COUNT DECREASED 162 0.0092
748 NERVOUS SYSTEM DISORDER 286 0.0092
749 HEAD DISCOMFORT 162 0.0091
750 ASPARTATE AMINOTRANSFERASE INCREASED 485 0.0091
751 TASTE DISORDER 184 0.0091
752 MEDICATION ERROR 504 0.0091
753 HYPOKALAEMIA 417 0.0090
754 COUGH 2532 0.0090
755 FLUID RETENTION 458 0.0090
756 CARDIAC ARREST 742 0.0090
757 VOMITING 4210 0.0089
758 RASH MACULO-PAPULAR 198 0.0089
759 CHOLECYSTITIS 106 0.0089
760 BRONCHITIS 656 0.0089
761 ABDOMINAL PAIN UPPER 1821 0.0088
762 GASTROINTESTINAL HAEMORRHAGE 735 0.0088
763 DRUG INEFFECTIVE 11584 0.0088
764 PREMATURE BABY 261 0.0087
765 NODULE 112 0.0086
766 VENTRICULAR TACHYCARDIA 139 0.0084
767 PAIN IN JAW 238 0.0084
768 DEEP VEIN THROMBOSIS 545 0.0084
769 MIGRAINE 797 0.0083
770 MELAENA 182 0.0083
771 PARALYSIS 118 0.0082
772 IMMUNE SYSTEM DISORDER 108 0.0082
773 MEMORY IMPAIRMENT 1112 0.0081
774 PLATELET COUNT INCREASED 105 0.0080
775 COLON CANCER 120 0.0080
776 APHASIA 243 0.0080
777 VISUAL IMPAIRMENT 989 0.0080
778 BLINDNESS UNILATERAL 112 0.0079
779 CARDIO-RESPIRATORY ARREST 332 0.0079
780 PLATELET COUNT DECREASED 843 0.0079
781 EYE PAIN 444 0.0079
782 ASTHENIA 2945 0.0078
783 SKIN DISORDER 261 0.0078
784 EOSINOPHILIA 137 0.0078
785 HEPATIC STEATOSIS 145 0.0078
786 DYSPNOEA 4371 0.0077
787 EJECTION FRACTION DECREASED 120 0.0077
788 QUALITY OF LIFE DECREASED 103 0.0077
789 ACNE 579 0.0076
790 NEOPLASM MALIGNANT 508 0.0076
791 GASTROENTERITIS VIRAL 137 0.0076
792 DIABETES MELLITUS INADEQUATE CONTROL 134 0.0076
793 RED BLOOD CELL COUNT DECREASED 216 0.0075
794 PRESYNCOPE 183 0.0075
795 SUBDURAL HAEMATOMA 107 0.0075
796 ARTHRALGIA 3097 0.0074
797 HYPOTENSION 1476 0.0074
798 VISUAL ACUITY REDUCED 244 0.0073
799 RHABDOMYOLYSIS 306 0.0073
800 UPPER GASTROINTESTINAL HAEMORRHAGE 123 0.0073
801 PRODUCT PRESCRIBING ERROR 174 0.0073
802 IMPAIRED QUALITY OF LIFE 105 0.0073
803 RASH 3182 0.0073
804 METASTASES TO LIVER 127 0.0072
805 BLOOD CREATINE PHOSPHOKINASE INCREASED 208 0.0072
806 ATRIAL FIBRILLATION 701 0.0072
807 BACK DISORDER 117 0.0072
808 PULMONARY EMBOLISM 671 0.0071
809 DYSPHAGIA 666 0.0070
810 HYPOPHAGIA 179 0.0070
811 ISCHAEMIC STROKE 124 0.0069
812 DEHYDRATION 920 0.0069
813 DYSURIA 253 0.0069
814 INFLUENZA 764 0.0068
815 ACUTE MYOCARDIAL INFARCTION 202 0.0068
816 PARAESTHESIA 1076 0.0068
817 HEART RATE DECREASED 240 0.0068
818 MALAISE 2992 0.0068
819 FEELING HOT 415 0.0068
820 BLOOD PRESSURE INCREASED 1022 0.0067
821 LOCALISED INFECTION 161 0.0067
822 HEADACHE 4134 0.0066
823 METASTASES TO BONE 108 0.0066
824 HYPOTHYROIDISM 209 0.0065
825 HEART RATE INCREASED 645 0.0065
826 INSOMNIA 1701 0.0064
827 ADVERSE EVENT 580 0.0063
828 ANAPHYLACTIC REACTION 347 0.0063
829 GAIT DISTURBANCE 1194 0.0062
830 CHILLS 724 0.0062
831 WHITE BLOOD CELL COUNT DECREASED 668 0.0062
832 HERNIA 119 0.0061
833 FATIGUE 4781 0.0061
834 NECK PAIN 343 0.0061
835 POOR QUALITY SLEEP 132 0.0061
836 DEPRESSED LEVEL OF CONSCIOUSNESS 240 0.0061
837 DERMATITIS 127 0.0061
838 RENAL INJURY 180 0.0061
839 DEAFNESS 158 0.0060
840 FOETAL EXPOSURE DURING PREGNANCY 490 0.0060
841 DEPRESSION 1355 0.0059
842 NAUSEA 4708 0.0059
843 CORONARY ARTERY DISEASE 180 0.0059
844 PRURITUS 2282 0.0059
845 MUSCLE SPASMS 1088 0.0059
846 ARRHYTHMIA 278 0.0059
847 SLEEP APNOEA SYNDROME 111 0.0058
848 FOOT FRACTURE 110 0.0058
849 SEIZURE 669 0.0058
850 PSYCHOTIC DISORDER 171 0.0058
851 HALLUCINATION, VISUAL 121 0.0057
852 SCAR 98 0.0057
853 DRUG ERUPTION 100 0.0056
854 PAIN IN EXTREMITY 1660 0.0056
855 TREMOR 935 0.0056
856 DYSARTHRIA 212 0.0056
857 EYE DISORDER 185 0.0056
858 BONE DISORDER 102 0.0056
859 ADVERSE DRUG REACTION 502 0.0056
860 CONJUNCTIVITIS 103 0.0055
861 URINARY RETENTION 185 0.0055
862 DISORIENTATION 217 0.0055
863 RIB FRACTURE 112 0.0054
864 FRACTURE 103 0.0054
865 INTESTINAL OBSTRUCTION 205 0.0054
866 HAEMORRHOIDS 106 0.0054
867 THROAT IRRITATION 240 0.0053
868 EPISTAXIS 398 0.0053
869 ANXIETY 1505 0.0053
870 IMPAIRED WORK ABILITY 113 0.0053
871 NEURALGIA 128 0.0053
872 OROPHARYNGEAL PAIN 485 0.0052
873 BLOOD PRESSURE DECREASED 348 0.0052
874 BLOOD POTASSIUM DECREASED 157 0.0052
875 HAEMORRHAGE 542 0.0052
876 CONVULSION 295 0.0052
877 PLASMA CELL MYELOMA 201 0.0051
878 THROMBOSIS 414 0.0051
879 MYALGIA 872 0.0051
880 UNDERDOSE 373 0.0051
881 LUNG NEOPLASM MALIGNANT 208 0.0051
882 BLOOD PRESSURE ABNORMAL 98 0.0049
883 RASH PRURITIC 267 0.0049
884 ORAL PAIN 110 0.0049
885 CHOLELITHIASIS 161 0.0049
886 NEUROPATHY PERIPHERAL 466 0.0049
887 DIZZINESS 2440 0.0049
888 TINNITUS 224 0.0049
889 PAIN 2993 0.0049
890 HAEMATOCHEZIA 268 0.0049
891 CARDIOVASCULAR DISORDER 123 0.0048
892 MENTAL DISORDER 210 0.0048
893 ANGIOEDEMA 207 0.0047
894 RHINORRHOEA 302 0.0047
895 LETHARGY 268 0.0047
896 ABDOMINAL DISTENSION 486 0.0047
897 NO ADVERSE EVENT 833 0.0046
898 SOMNOLENCE 920 0.0046
899 ABDOMINAL PAIN LOWER 115 0.0045
900 ANGINA PECTORIS 130 0.0045
901 LACTIC ACIDOSIS 144 0.0044
902 BRADYCARDIA 231 0.0044
903 RASH ERYTHEMATOUS 208 0.0043
904 NEPHROLITHIASIS 199 0.0043
905 DRY EYE 216 0.0043
906 SYNCOPE 425 0.0042
907 COGNITIVE DISORDER 196 0.0042
908 BONE DENSITY DECREASED 131 0.0042
909 GASTRIC DISORDER 143 0.0042
910 LIMB INJURY 113 0.0042
911 UNRESPONSIVE TO STIMULI 107 0.0041
912 SPEECH DISORDER 216 0.0041
913 NASAL CONGESTION 242 0.0041
914 PALLOR 111 0.0041
915 NEUTROPHIL COUNT DECREASED 163 0.0040
916 PSORIASIS 522 0.0040
917 DEATH 3389 0.0039
918 ILLNESS 400 0.0039
919 LOSS OF CONSCIOUSNESS 496 0.0039
920 THERAPEUTIC RESPONSE SHORTENED 127 0.0038
921 HIP FRACTURE 123 0.0038
922 HOSPITALISATION 585 0.0038
923 DYSPHONIA 222 0.0038
924 CEREBROVASCULAR ACCIDENT 636 0.0038
925 URINARY INCONTINENCE 111 0.0037
926 HYPOGLYCAEMIA 179 0.0037
927 CHEST DISCOMFORT 372 0.0036
928 BACK PAIN 832 0.0036
929 VERTIGO 218 0.0036
930 VISION BLURRED 485 0.0035
931 INTERNATIONAL NORMALISED RATIO INCREASED 99 0.0035
932 ACCIDENTAL OVERDOSE 127 0.0035
933 FALL 1151 0.0035
934 ERYTHEMA 703 0.0034
935 DRUG EFFECT INCOMPLETE 123 0.0034
936 CARDIAC FAILURE CONGESTIVE 272 0.0034
937 DRUG EXPOSURE DURING PREGNANCY 113 0.0033
938 SWELLING FACE 216 0.0033
939 MOVEMENT DISORDER 105 0.0033
940 SURGERY 191 0.0033
941 LIMB DISCOMFORT 100 0.0032
942 CARDIAC DISORDER 301 0.0032
943 POLLAKIURIA 134 0.0032
944 SKIN DISCOLOURATION 147 0.0032
945 INTENTIONAL PRODUCT MISUSE 276 0.0031
946 DISTURBANCE IN ATTENTION 167 0.0031
947 DEPRESSED MOOD 162 0.0031
948 AGITATION 223 0.0030
949 ECZEMA 157 0.0030
950 MYOCARDIAL INFARCTION 514 0.0029
951 PALPITATIONS 341 0.0029
952 TRANSIENT ISCHAEMIC ATTACK 98 0.0029
953 THERAPY INTERRUPTED 207 0.0029
954 HALLUCINATION 216 0.0029
955 BLOOD GLUCOSE INCREASED 535 0.0028
956 OVERDOSE 577 0.0027
957 THERAPY CESSATION 136 0.0026
958 BURNING SENSATION 184 0.0026
959 BALANCE DISORDER 218 0.0025
960 BONE PAIN 145 0.0025
961 INFLUENZA LIKE ILLNESS 202 0.0025
962 SKIN EXFOLIATION 207 0.0025
963 DYSKINESIA 99 0.0024
964 FLUSHING 239 0.0023
965 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 418 0.0023
966 CONSTIPATION 487 0.0022
967 UNEVALUABLE EVENT 163 0.0022
968 DERMATITIS ATOPIC 113 0.0021
969 HYPERHIDROSIS 272 0.0021
970 OCULAR HYPERAEMIA 100 0.0021
971 PROSTATE CANCER 166 0.0021
972 MALIGNANT NEOPLASM PROGRESSION 211 0.0021
973 PRODUCT DOSE OMISSION ISSUE 595 0.0020
974 FLATULENCE 114 0.0020
975 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 102 0.0020
976 IRRITABILITY 115 0.0019
977 FEELING ABNORMAL 454 0.0019
978 BREAST CANCER 172 0.0018
979 SUICIDAL IDEATION 154 0.0017
980 DYSGEUSIA 119 0.0016
981 HOT FLUSH 118 0.0016
982 PRODUCT QUALITY ISSUE 198 0.0015
983 EMOTIONAL DISTRESS 176 0.0015
984 DRY SKIN 187 0.0014
985 DRUG DOSE OMISSION 224 0.0014
986 INCORRECT DOSE ADMINISTERED 303 0.0013
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 189 0.0009
988 DRUG DEPENDENCE 125 0.0008
989 INJECTION SITE PAIN 187 0.0006